RenovoRx, Inc.
Support and Resistance Levels
Past performance
News About RNXT
All events for RNXT
All deals for RNXT
Financial Ratios
Financial Statements
RNXT vs Sector & Peers
About RenovoRx, Inc.
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California. Website renovorx.com
Headquarters Mountain View, CA, US